Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
:GH
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.8Last Year’s EPS
-0.88Same Quarter Last Year
Strong Buy
Based on 16 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong performance across all major business segments, with significant revenue growth and improved gross margins. While there are minor concerns about ASP adjustments and regulatory uncertainties, the overall outlook remains positive due to strong execution and increased guidance.Company Guidance -
Q3 2025
Record Revenue Growth
Q2 revenue grew 31% year-over-year to $232 million, driven by strong performance across oncology, biopharma, and screening segments.
Oncology Segment Performance
Oncology revenue increased 22% to $159 million with a 30% year-over-year increase in test volumes. Guardant360 Liquid saw over 20% growth, marking the fourth consecutive quarter of acceleration.
Biopharma Segment Achievements
Biopharma and data business achieved record revenue of $56 million, a 28% increase year-over-year, with new companion diagnostic deals signed.
Shield Screening Success
Shield testing generated $15 million in Q2, with approximately 16,000 tests conducted and a high adherence rate of over 90%.
Gross Margin Improvement
Non-GAAP gross margin improved to 66%, with Shield's non-GAAP gross margin increasing to 48% from 18% in Q1 2025.
Guidance Increase
Full-year 2025 revenue guidance increased to $915-$925 million, reflecting expected growth in oncology and Shield revenues.
GH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 30, 2025 | $45.19 | $40.98 | -9.32% |
Apr 30, 2025 | $47.23 | $48.87 | +3.47% |
Feb 20, 2025 | $47.40 | $42.87 | -9.56% |
Nov 06, 2024 | $25.29 | $28.59 | +13.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Guardant Health (GH) report earnings?
Guardant Health (GH) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Guardant Health (GH) earnings time?
Guardant Health (GH) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GH EPS forecast?
GH EPS forecast for the fiscal quarter 2025 (Q3) is -0.8.